cpd-1028
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02134340)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Insulin-like growth factor I receptorImmunity, passive
IGF1R immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- cpd-1028
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02134340 | Phase 1 | Jun 1, 2014 | Centre for Probe Development and Commercialization |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centre for Probe Development and Commercialization | Academic/Hospital | 1 | 1 | 1 | 2014 |
1 organizations
Page 1 / 1